201 results
Keyword Enalapril Almus Remove keyword
-
List item
Referral: Renitec
Enalapril, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/09/2002, EC decision date: 21/05/2003, Last updated: 02/12/2003Enalapril is a highly specific, competitive … the benefit/risk ratio of enalapril is considered to be favourable … Renitec, INN-Enalapril The European Agency … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Enalapril (maleate)
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-001706-PIP01-14-M02, Route(s) of administration: Oral use, Pharmaceutical form(s): Age-appropriate oral solid dosage form
Decision date: 07/12/2018, Last updated: 20/02/2019, Compliance check: XActive substance Enalapril (maleate) Therapeutic area … Enalapril (maleate … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Enalapril (maleate)
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-001241-PIP02-13-M01, Route(s) of administration: Oral use, Pharmaceutical form(s): Oral solution
Decision date: 03/09/2014, Last updated: 29/09/2014, Compliance check: XActive substance Enalapril (maleate) Therapeutic area … paediatric investigation plan for enalapril (maleate) (EMEA-001241-PIP02-13-M01 … paediatric investigation plan for enalapril (maleate) (EMEA-001241-PIP02-13-M01 … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Enalapril (maleate)
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-001516-PIP01-13, Route(s) of administration: Oral use, Pharmaceutical form(s): Tablet for oral suspension, Orodispersible film
Decision date: 05/05/2014, Last updated: 06/06/2014, Compliance check: XActive substance Enalapril (maleate) Therapeutic area … the refusal of a waiver for enalapril (maleate) (EMEA-001516-PIP01-13 … the refusal of a waiver for enalapril (maleate) (EMEA-001516-PIP01-13 … -
List item
Referral: Renin-angiotensin-system (RAS)-acting agents
captopril, imidapril, zofenopril, candesartan, delapril, telmisartan, aliskiren, moexipril, enalapril, valsartan, fosinopril, irbesartan, perindopril, quinapril, ramipril, eprosartan, olmesartan, trandolapril, losartan, azilsartan, lisinopril, spirapril, benazepril, cilazapril, associated names: Tolucombi, Telmisartan Teva, Telmisartan Teva Pharma, Tolura, Onduarp, Twynsta, Actelsar HCT, Kinzalkomb, MicardisPlus, PritorPlus, Copalia HCT, Dafiro HCT, Exforge HCT, Rasilamlo, Rasilez, Rasilez HCT, Rasitrio, Edarbi, Ipreziv, Aprovel, Ifirmasta (previously Irbesartan Krka), Irbesartan Teva, Irbesartan Zentiva (previously Irbesartan Winthrop), Karvea, Sabervel, CoAprovel, Ifirmacombi, Irbesartan/Hydrochlorothiazide Teva, Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop), Karvezide, Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG), Micardis, Pritor, Telmisartan Actavis, Article 31 referrals
Status: European Commission final decision, opinion/position date: 22/05/2014, EC decision date: 04/09/2014, Last updated: 08/10/2014Actavis captopril imidapril zofenopril candesartan delapril telmisartan aliskiren moexipril enalapril valsartan fosinopril irbesartan perindopril quinapril ramipril eprosartan olmesartan trandolapril losartan azilsartan lisinopril spirapril benazepril cilazapril captopril … -
List item
Human medicine European public assessment report (EPAR): Entresto
sacubitril, valsartan, Heart Failure
Date of authorisation: 19/11/2015, Revision: 12, Authorised, Last updated: 07/12/2020Entresto was compared to enalapril, another medicine used for … 4,212) patients treated with enalapril. In general, patients were … Entresto was more effective than enalapril. What are the risks associated … -
List item
Human medicine European public assessment report (EPAR): Neparvis (updated)
sacubitril, valsartan, Heart Failure
Date of authorisation: 26/05/2016,
, Revision: 11, Authorised, Last updated: 24/02/2021
Neparvis was compared to enalapril, another medicine used for … 4,212) patients treated with enalapril. In general, patients were … Neparvis was more effective than enalapril. What are the risks associated … -
List item
National expert: Carla Torre, National Authority of Medicines and Health Products, I.P. (updated)
- Declaration of interests - 80.23 KB | PDF
- Curriculum Vitae - 21.71 KB | PDF
reviewed indexed journals: Al-Musawe L, Torre C, Guerreiro JP … 10.3389/fmed.2019.00147. Al-Musawe L, Paula Martins A, Filipe … -
List item
Human medicine European public assessment report (EPAR): Karvea (updated)
irbesartan, Hypertension
Date of authorisation: 26/08/1997, Revision: 40, Authorised, Last updated: 01/03/2021for hypertension (atenolol, enalapril or amlodipine) in 823 patients … hypertension (atenolol, enalapril or amlodipine) in 823 patients … -
List item
Human medicine European public assessment report (EPAR): Irbesartan Zentiva (previously Irbesartan Winthrop)
irbesartan, Hypertension
Date of authorisation: 19/01/2007, Revision: 23, Authorised, Last updated: 18/11/2020for hypertension (atenolol, enalapril or amlodipine) in 823 patients … hypertension (atenolol, enalapril or amlodipine) in 823 patients … -
List item
Press release: New medicine to treat heart failure recommended for approval
CHMP, Last updated: 25/09/2015of Entresto compared with enalapril (an ACE inhibitor) was assessed … Entresto was more effective than enalapril in reducing deaths from cardiovascular … the patients treated with enalapril. The trial also found that … -
List item
Human medicine European public assessment report (EPAR): Micardis
telmisartan, Hypertension
Date of authorisation: 16/12/1998, Revision: 24, Authorised, Last updated: 18/12/2020hypertension (atenolol, lisinopril, enalapril and amlodipine). The main … hypertension (atenolol, lisinopril, enalapril and amlodipine). The main … -
List item
Human medicine European public assessment report (EPAR): Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG)
telmisartan, Hypertension
Date of authorisation: 16/12/1998, Revision: 30, Authorised, Last updated: 18/12/2020hypertension (atenolol, lisinopril, enalapril and amlodipine). The main … hypertension (atenolol, lisinopril, enalapril and amlodipine). The main … -
List item
Human medicine European public assessment report (EPAR): Pritor
telmisartan, Hypertension
Date of authorisation: 11/12/1998, Revision: 29, Authorised, Last updated: 10/12/2020hypertension (atenolol, lisinopril, enalapril and amlodipine). The main … hypertension (atenolol, lisinopril, enalapril and amlodipine). The main … -
List item
National expert: David Duguay, European Medicines Agency (updated)
- Declaration of interests - 79.75 KB | PDF
- Curriculum Vitae - 21.7 KB | PDF
receptor is not involved in enalapril-induced apoptosis and regression … D. Synergistic interaction between enalapril and nitric oxide enhancing … rat heart with valsartan or enalapril. Cardiovascular Research 2003 … -
List item
National expert: Karin Weisser, Paul-Ehrlich-Institute (updated)
- Declaration of interests - 79.76 KB | PDF
- Curriculum Vitae - 81.48 KB | PDF
-
List item
Human medicine European public assessment report (EPAR): Aprovel (updated)
irbesartan, Hypertension
Date of authorisation: 26/08/1997, Revision: 42, Authorised, Last updated: 01/03/2021for hypertension (atenolol, enalapril or amlodipine) in 823 patients … hypertension (atenolol, enalapril or amlodipine) in 823 patients … -
List item
National expert: Ioannis Niopas, National Organization for Medicines (updated)
- Declaration of interests - 79.77 KB | PDF
- Curriculum Vitae - 25.41 KB | PDF
-
List item
National expert: Claus Stage, Danish Medicines Agency (updated)
- Declaration of interests - 80.94 KB | PDF
- Curriculum Vitae - 18.93 KB | PDF
Consortium. The Pharmacokinetics of Enalapril in Relation to CES1 Genotype in … two clinical trials with enalapril (Corodil®) and methylphenidate … -
List item
National expert: Jana Klimasová, State Institute for Drug Control (updated)
- Declaration of interests - 80.04 KB | PDF
- Curriculum Vitae - 80.03 KB | PDF
short- term ACE inhibition (by enalaprilat) alters contractile performance … P, Ochodnicky P, Klimas J: Enalaprilat increases PPARβ/δ expression … -
List item
Press release: PRAC recommends against combined use of medicines affecting the renin-angiotensin (RAS) system
PRAC, Last updated: 11/04/2014captopril, cilazapril, delapril, enalapril, fosinopril, imidapril, lisinopril … captopril, cilazapril, delapril, enalapril, fosinopril, imidapril, lisinopril … -
List item
National expert: Aristeidis Dokoumetzidis, European Medicines Agency (updated)
- Declaration of interests - 80.9 KB | PDF
- Curriculum Vitae - 25.93 KB | PDF
03/2013-11/2013 Pharmathen SA Enalapril Hypertension 2.3 Strategic … -
List item
National expert: Xavier Bosch, Spanish Agency of Medicines and Medical Devices (updated)
- Declaration of interests - 79.78 KB | PDF
- Curriculum Vitae - 52.63 KB | PDF
-
List item
National expert: Caridad Pontes, Spanish Agency of Medicines and Medical Devices (updated)
- Declaration of interests - 80.91 KB | PDF
- Curriculum Vitae - 40.59 KB | PDF
-
List item
Human medicine European public assessment report (EPAR): Karvezide (updated)
irbesartan, hydrochlorothiazide, Hypertension
Date of authorisation: 16/10/1998, Revision: 40, Authorised, Last updated: 01/03/2021